{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:20:04Z","timestamp":1790162404832,"version":"4.1.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001193","name":"Sir Edward Dunlop Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Multiple proteinases are present in the synovial fluid (SF) of an arthritic joint. We aimed to identify inflammatory cell populations present in psoriatic arthritis (PsA) SF compared to osteoarthritis (OA) and rheumatoid arthritis (RA), identify their proteinase-activated receptor 2 (PAR2) signaling function and characterize potentially active SF serine proteinases that may be PAR2 activators.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Flow cytometry was used to characterize SF cells from PsA, RA, OA patients; PsA SF cells were further characterized by single cell 3\u2019-RNA-sequencing. Active serine proteinases were identified through cleavage of fluorogenic trypsin- and chymotrypsin-like substrates, activity-based probe analysis and proteomics. Fluo-4 AM was used to monitor intracellular calcium cell signaling. Cytokine expression was evaluated using a multiplex Luminex panel.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>PsA SF cells were dominated by monocytes\/macrophages, which consisted of three populations representing classical, non-classical and intermediate cells. The classical monocytes\/macrophages were reduced in PsA compared to OA\/RA, whilst the intermediate population was increased. PAR2 was elevated in OA vs. PsA\/RA SF monocytes\/macrophages, particularly in the intermediate population. PAR2 expression and signaling in primary PsA monocytes\/macrophages significantly impacted the production of monocyte chemoattractant protein-1 (MCP-1). Trypsin-like serine proteinase activity was elevated in PsA and RA SF compared to OA, while chymotrypsin-like activity was elevated in RA compared to PsA. Tryptase-6 was identified as an active serine proteinase in SF that could trigger calcium signaling partially <jats:italic>via<\/jats:italic> PAR2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>PAR2 and its activating proteinases, including tryptase-6, can be important mediators of inflammation in PsA. Components within this proteinase-receptor axis may represent novel therapeutic targets.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2020.629726","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T04:18:37Z","timestamp":1615177117000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Proteinase-Mediated Macrophage Signaling in Psoriatic Arthritis"],"prefix":"10.3389","volume":"11","author":[{"given":"Fatima","family":"Abji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozhgan","family":"Rasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"G\u00f3mez-Aristiz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Muytjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Saifeddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Motahhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowmya","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morley D.","family":"Hollenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Oikonomopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0b013e3283534df4","article-title":"Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory","volume":"24","author":"Ambarus","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-018-8702-3","article-title":"The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B3","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1002\/art.30117","article-title":"Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor alpha therapy: results from the nationwide Danish DANBIO registry","volume":"63","author":"Glintborg","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2012-201933","article-title":"Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor alpha inhibitor therapy: results from the Danish nationwide DANBIO registry","volume":"72","author":"Glintborg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.27227","article-title":"Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry","volume":"62","author":"Hetland","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1038\/nrrheum.2018.17","article-title":"Proteinases and their receptors in inflammatory arthritis: an overview","volume":"14","author":"Oikonomopoulou","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1053\/berh.2001.0195","article-title":"Metalloproteases and inhibitors in arthritic diseases","volume":"15","author":"Martel-Pelletier","year":"2001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2017.04.015","article-title":"Matrix metalloproteinase collagenolysis in health and disease","volume":"1864","author":"Amar","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B10","article-title":"Cysteine proteinases in arthritis and inflammation","volume":"6","author":"MullerLadner","year":"1996","journal-title":"Perspect Drug Discov"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1002\/jemt.10374","article-title":"Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities","volume":"61","author":"Delaiss\u00e9","year":"2003","journal-title":"Microsc Res Tech"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1002\/1529-0131(200108)44:8<1744::AID-ART309>3.0.CO;2-K","article-title":"Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis","volume":"44","author":"Cunnane G","year":"2001","journal-title":"Arthritis Rheum"},{"key":"B13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1559-0275-11-27","article-title":"Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry","volume":"11","author":"Cretu","year":"2014","journal-title":"Clin Proteomics"},{"key":"B14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13075-017-1417-7","article-title":"Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study","volume":"19","author":"Jadon","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B15","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1186\/1471-2474-15-93","article-title":"The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases","volume":"15","author":"Sun","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1038\/nrrheum.2017.125","article-title":"The complement system as a potential therapeutic target in rheumatic disease","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1111\/j.1538-7836.2003.00462.x","article-title":"Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways","volume":"1","author":"So","year":"2003","journal-title":"J Thromb Haemost"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1002\/art.10498","article-title":"Extravascular coagulation and the plasminogen activator\/plasmin system in rheumatoid arthritis","volume":"46","author":"Busso","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B20","article-title":"Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage","volume":"18","author":"Martel-Pelletier","year":"1991","journal-title":"J Rheumatol"},{"key":"B21","article-title":"Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis","volume":"17","author":"Nakano","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2012-0251","article-title":"Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease","volume":"51","author":"Eissa","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1124\/pr.115.010991","article-title":"Proteinases, Their Extracellular Targets, and Inflammatory Signaling","volume":"68","author":"Ramachandran","year":"2016","journal-title":"Pharmacol Rev"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2011.01.003","article-title":"Structure, function and pathophysiology of protease activated receptors","volume":"130","author":"Adams","year":"2011","journal-title":"Pharmacol Ther"},{"key":"B25","article-title":"Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms","volume":"66","author":"Jackson","year":"2014","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2011-200869","article-title":"Immunomodulatory role of proteinase-activated receptor-2","volume":"71","author":"Crilly","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1002\/art.24300","article-title":"Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice","volume":"60","author":"McDougall","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI16913","article-title":"Essential role for proteinase-activated receptor-2 in arthritis","volume":"111","author":"Ferrell","year":"2003","journal-title":"J Clin Invest"},{"key":"B29","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1186\/ar2329","article-title":"Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study","volume":"9","author":"Boileau","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.105.093807","article-title":"Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation","volume":"316","author":"Kelso","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI11064","article-title":"Amelioration of collagen-induced arthritis by thrombin inhibition","volume":"107","author":"Marty","year":"2001","journal-title":"J Clin Invest"},{"key":"B32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/art.33323","article-title":"Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis","volume":"64","author":"Xue","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-011-2102-9","article-title":"Correlation of protease-activated receptor-2 expression and synovitis in rheumatoid and osteoarthritis","volume":"32","author":"Tindell","year":"2012","journal-title":"Rheumatol Int"},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.100710","article-title":"Proteinase-activated receptor-2 gene disruption limits the effect of osteoarthritis on cartilage in mice: a novel target in joint degradation","volume":"38","author":"Amiable","year":"2011","journal-title":"J Rheumatol"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2010.130336","article-title":"Protease-activated receptor 2: a novel pathogenic pathway in a murine model of osteoarthritis","volume":"69","author":"Ferrell","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.1002\/art.22312","article-title":"Evaluation of protease-activated receptor 2 in murine models of arthritis","volume":"56","author":"Busso","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.1007\/s00011-009-8087-0","article-title":"Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation","volume":"58","author":"Russell","year":"2009","journal-title":"Inflammation Res"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M112.438184","article-title":"Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling","volume":"288","author":"Poole","year":"2013","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0b013e32805e87ae","article-title":"Macrophages and their products in rheumatoid arthritis","volume":"19","author":"Szekanecz","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B41","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"key":"B43","article-title":"Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis","volume":"12","author":"Cochain","year":"2018","journal-title":"Circ Res"},{"key":"B44","article-title":"CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) \/CD16(neg) monocytes: Expansion of CD14(hi) \/CD16(pos) and contraction of CD14(lo) \/CD16(pos) monocytes in acute liver failure","volume":"81","author":"Abeles","year":"2012","journal-title":"Cytometry A"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2006.468","article-title":"In-gel digestion for mass spectrometric characterization of proteins and proteomes","volume":"1","author":"Shevchenko","year":"2006","journal-title":"Nat Protoc"},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2016.136","article-title":"The MaxQuant computational platform for mass spectrometry-based shotgun proteomics","volume":"11","author":"Tyanova","year":"2016","journal-title":"Nat Protoc"},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat Methods"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2013.02.023","article-title":"Cleaning up the masses: exclusion lists to reduce contamination with HPLC-MS\/MS","volume":"88","author":"Hodge","year":"2013","journal-title":"J Proteomics"},{"key":"B49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2006.03.012","article-title":"Development of activity-based probes for trypsin-family serine proteases","volume":"16","author":"Pan","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"B50","doi-asserted-by":"crossref","first-page":"7834","DOI":"10.1038\/s41598-018-26282-y","article-title":"Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease","volume":"8","author":"Denadai-Souza","year":"2018","journal-title":"Sci Rep"},{"key":"B51","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M707253200","article-title":"Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin","volume":"283","author":"Emami","year":"2008","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1515\/hsz-2011-0251","article-title":"Proteinase-activated receptors (PARs): differential signalling by kallikrein-related peptidases KLK8 and KLK14","volume":"393","author":"Ramachandran","year":"2012","journal-title":"Biol Chem"},{"key":"B53","doi-asserted-by":"crossref","DOI":"10.1111\/bph.12544","article-title":"Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease","volume":"171","author":"Hollenberg","year":"2014","journal-title":"Br J Pharmacol"},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.108.136432","article-title":"Derivatized 2-furoyl-LIGRLO-amide, a versatile and selective probe for proteinase-activated receptor 2: binding and visualization","volume":"326","author":"Hollenberg","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.117.245027","article-title":"A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells","volume":"364","author":"Jiang","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"B56","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M513138200","article-title":"Proteinase-activated receptors, targets for kallikrein signaling","volume":"281","author":"Oikonomopoulou","year":"2006","journal-title":"J Biol Chem"},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.1124\/mol.117.109017","article-title":"Transforming Growth Factor- \u03b2 1\/Activin Receptor-like Kinase 5-Mediated Cell Migration is Dependent on the Protein Proteinase-Activated Receptor 2 but not on Proteinase-Activated Receptor 2-Stimulated G q-Calcium Signaling","volume":"92","author":"Ungefroren","year":"2017","journal-title":"Mol Pharmacol"},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1111\/cea.12921","article-title":"Cockroach allergen serine proteinases: Isolation, sequencing and signalling via proteinase-activated receptor-2","volume":"47","author":"Polley","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"B59","doi-asserted-by":"crossref","DOI":"10.1128\/CDLI.7.6.920-924.2000","article-title":"Measurement of Cytokine Secretion, Intracellular Protein Expression, and mRNA in Resting and Stimulated Peripheral Blood Mononuclear Cells","volume":"7","author":"Sullivan","year":"2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"B60","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.67.11.5573-5578.1999","article-title":"Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB","volume":"67","author":"Takashiba","year":"1999","journal-title":"Infect Immun"},{"key":"B61","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt953","article-title":"MEROPS: the database of proteolytic enzymes, their substrates and inhibitors","author":"Rawlings","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/bj20030242","article-title":"A novel serine protease predominately expressed in macrophages","volume":"374","author":"Chen","year":"2003","journal-title":"Biochem J"},{"key":"B63","doi-asserted-by":"crossref","DOI":"10.1002\/jlb.59.4.555","article-title":"Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3","volume":"59","author":"Schwende","year":"1996","journal-title":"J Leukoc Biol"},{"key":"B64","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2002-08-2497","article-title":"Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells","volume":"102","author":"Colognato","year":"2003","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"crossref","DOI":"10.1002\/art.21001","article-title":"Reduction of arthritis severity in protease-activated receptor-deficient mice","volume":"52","author":"Yang","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B66","doi-asserted-by":"crossref","DOI":"10.1002\/art.22423","article-title":"Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist","volume":"56","author":"Kelso","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B67","doi-asserted-by":"crossref","DOI":"10.1038\/nrrheum.2016.91","article-title":"Macrophage heterogeneity in the context of rheumatoid arthritis","volume":"12","author":"Udalova","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B68","article-title":"The macrophages in rheumatic diseases","volume":"9","author":"Laria","year":"2016","journal-title":"J Inflamm Res"},{"key":"B69","doi-asserted-by":"crossref","DOI":"10.1006\/cyto.2000.0720","article-title":"Human monocytes express CD163, which is upregulated by IL-10 and identical to p155","volume":"12","author":"Sulahian","year":"2000","journal-title":"Cytokine"},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.1002\/path.1044","article-title":"Macrophages expressing the scavenger receptor CD163: link between immune alterations of the gut and synovial inflammation in spondyloarthropathy","volume":"196","author":"Baeten","year":"2002","journal-title":"J Pathol"},{"key":"B71","doi-asserted-by":"crossref","DOI":"10.1186\/1423-0127-18-43","article-title":"Anti-Inflammatory mechanisms of the proteinase-activated receptor 2-inhibiting peptide in human synovial cells","author":"Chen","year":"2011","journal-title":"J BioMed Sci"},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-208268","article-title":"Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathology","volume":"75","author":"Huesa","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B73","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2011-200703","article-title":"PAR2 expression in peripheral blood monocytes of patients with rheumatoid arthritis","volume":"71","author":"Crilly","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B74","article-title":"Proteinase-activated receptor 2 expression on peripheral blood monocytes and T-cells in patients with rheumatoid arthritis","volume":"38","author":"Kandel","year":"2015","journal-title":"Egypt Rheumatol"},{"key":"B75","article-title":"PAR2 promotes M1 macrophage polarization and inflammation via FOXO1 pathway","volume":"120","author":"Chen","year":"2019","journal-title":"J Cell Biochem"},{"key":"B76","doi-asserted-by":"crossref","DOI":"10.1002\/mc.22020","article-title":"Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells","volume":"53","author":"Li","year":"2014","journal-title":"Mol Carcinog"},{"key":"B77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12929-017-0393-1","article-title":"Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells","volume":"24","author":"Chao","year":"2017","journal-title":"J BioMed Sci"},{"key":"B78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1753425910395044","article-title":"Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages","volume":"18","author":"Nhu","year":"2012","journal-title":"Innate Immun"},{"key":"B79","doi-asserted-by":"crossref","DOI":"10.1177\/1753425913479984","article-title":"Proteinase-activated receptor-2 modulates human macrophage differentiation and effector function","volume":"19","author":"Steven","year":"2013","journal-title":"Innate Immun"},{"key":"B80","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-12-326355","article-title":"Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets","volume":"118","author":"Wong","year":"2011","journal-title":"Blood"},{"key":"B82","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.241377298","article-title":"Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis","volume":"98","author":"Fiorucci","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B83","doi-asserted-by":"crossref","first-page":"e61923","DOI":"10.1371\/journal.pone.0061923","article-title":"Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model","volume":"8","author":"van den Hengel","year":"2013","journal-title":"PLoS One"},{"key":"B84","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)32244-5","article-title":"Prostasin is a novel human serine proteinase from seminal fluid: purification, tissue distribution, and localization in prostate gland","volume":"269","author":"Yu","year":"1994","journal-title":"J Biol Chem"},{"key":"B85","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.270.22.13483","article-title":"Molecular cloning, tissue-specific expression, and cellular localization of human prostasin mRNA","volume":"270","author":"Yu","year":"1995","journal-title":"J Biol Chem"},{"key":"B86","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.87.10.3811","article-title":"Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family","author":"Vanderslice","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B87","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.274.43.30784","article-title":"Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension","volume":"274","author":"Wong","year":"1999","journal-title":"J Biol Chem"},{"key":"B88","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2044.2004.03757.x","article-title":"Mast cell tryptase: a review of its physiology and clinical significance","volume":"59","author":"Payne","year":"2004","journal-title":"Anaesthesia"},{"key":"B89","doi-asserted-by":"crossref","DOI":"10.1016\/j.alit.2017.01.001","article-title":"Human eosinophils constitutively express a unique serine protease, PRSS33","volume":"66","author":"Toyama","year":"2017","journal-title":"Allergol Int"},{"key":"B90","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12931-018-0968-8","article-title":"Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases","volume":"20","author":"Sridhar","year":"2019","journal-title":"Respir Res"},{"key":"B91","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.anai.2018.11.025","article-title":"Distinct transcriptomic profiles of early-onset atopic dermatitis in blood and skin of pediatric patients","volume":"122","author":"Brunner","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B92","doi-asserted-by":"crossref","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte Chemoattractant Protein-1 (MCP-1): An Overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"}],"updated-by":[{"DOI":"10.3389\/fimmu.2021.814072","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.629726\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T18:20:59Z","timestamp":1648664459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.629726\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":92,"alternative-id":["10.3389\/fimmu.2020.629726"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.629726","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fimmu.2021.814072","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"article-number":"629726"}}